A set of gene variants originating in Sub-Saharan West Africa may help explain why black women have worse breast cancer outcomes than white women, say researchers at Weill Cornell Medicine and NewYork-Presbyterian.
A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria – a population that shows resistance to traditional flu and polio vaccine.
The Weill Cornell Medical College Class of 2019 learned on national Match Day where they will be doing their internship and residency training – the next three to seven years of their medical careers.
Dr. Carl Nathan, chairman of the Department of Microbiology and Immunology at Weill Cornell Medicine, was awarded the Joan and Sanford I. Weill Exemplary Achievement Award at a gala March 5.
Richard Cerione, the Goldwin Smith Professor of pharmacology and chemical biology, and Claudia Fischbach, professor of biomedical engineering, discuss their collaborative research on cancer biology – the metabolic changes required for cancer development and cancer cells' interactions with other cells.
Two Weill Cornell Medicine trauma surgeons held a pair of training sessions at Cornell Health for “Stop the Bleed,” a national effort to teach basic bleeding control.
The third annual NYC Health Hackathon, hosted Feb. 8-10 by Weill Cornell Medicine, brought teams together in an attempt to solve myriad medical challenges.
Research on blood flow in the brain, from the lab of Chris Schaffer and Nozomi Nishimura, could help inform better therapies for people with dementia, including Alzheimer's disease.
